Skip to main content
Top
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service

Authors: Husna Maulavizada, Lynne Emmerton, Hendrika Laetitia Hattingh

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

The pressure on healthcare services worldwide has driven the incorporation of disease state management services within community pharmacies in developed countries. Pharmacists are recognised as the most accessible healthcare professionals, and the incorporation of these services facilitates patient care. In Australia, the opportunity to manage pharmacy patients with mental illness has been underutilised, despite the existence of service models for other chronic conditions. This paper is an independent evaluation of a novel service developed by a community pharmacy in Perth, Western Australia. The service represents collaboration between a nurse practitioner and community pharmacy staff in the management of mental health patients with metabolic risks.

Methods

We applied practice service standards for Australian community pharmacies to develop an evaluation framework for this novel service. This was followed by semi-structured interviews with staff members at the study pharmacy to explore service processes and procedures. Descriptive analysis of interviews was supplemented with analysis of patients’ biometric data. All data were evaluated against the developed framework.

Results

The evaluation framework comprised 13 process, 5 outcomes, and 11 quality indicators. Interview data from eight staff members and biometric data from 20 community-dwelling mental health patients taking antipsychotics were evaluated against the framework. Predominantly, patients were managed by the pharmacy’s nurse practitioner, with medication management provided by pharmacists. Patients’ biometric measurements comprised weight, blood pressure, blood glucose levels, lipid profiles and management of obesity, smoking, hypertension and diabetes. Positive outcomes observed in the patient data included weight loss, smoking cessation, and improved blood pressure, blood glucose and lipid levels.

Conclusions

The developed framework allowed effective evaluation of the service, and may be applicable to other pharmacy services. The metabolic clinic met key process, quality and outcomes indicators. The positive patient outcomes may assist in securing further funding.
Appendix
Available only for authorised users
Literature
1.
go back to reference Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother. 2005;39(11):1911–7.CrossRefPubMed Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother. 2005;39(11):1911–7.CrossRefPubMed
2.
go back to reference Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41(5):861–8.CrossRefPubMed Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41(5):861–8.CrossRefPubMed
3.
go back to reference Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40(4):729–35.CrossRefPubMed Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother. 2006;40(4):729–35.CrossRefPubMed
4.
go back to reference Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006;40(3):512–7.CrossRefPubMed Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006;40(3):512–7.CrossRefPubMed
5.
go back to reference Armour CL, Reddel HK, Lemay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, Song YJC, Alles MC, Burton DL, Emmerton L . Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–9. Armour CL, Reddel HK, Lemay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, Song YJC, Alles MC, Burton DL, Emmerton L . Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–9.
6.
go back to reference Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Med. 2007;24(6):677–83. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Med. 2007;24(6):677–83.
9.
go back to reference Gardner A, Hase S, Gardner G, Dunn SV, Carryer J. From competence to capability: a study of nurse practitioners in clinical practice. J Clin Nurs. 2008;17(2):250–8.PubMed Gardner A, Hase S, Gardner G, Dunn SV, Carryer J. From competence to capability: a study of nurse practitioners in clinical practice. J Clin Nurs. 2008;17(2):250–8.PubMed
11.
go back to reference Bell JS, Rosen A, Aslani P, Whitehead P, Chen TF. Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals. Res Social Adm Pharmacy. 2007;3(4):392–409.CrossRef Bell JS, Rosen A, Aslani P, Whitehead P, Chen TF. Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals. Res Social Adm Pharmacy. 2007;3(4):392–409.CrossRef
12.
go back to reference Duhoux A, Fournier L, Gauvin L, Roberge P. Quality of care for major depression and its determinants: a multilevel analysis. BMC Psychiatry. 2012;12(1):142.CrossRefPubMedPubMedCentral Duhoux A, Fournier L, Gauvin L, Roberge P. Quality of care for major depression and its determinants: a multilevel analysis. BMC Psychiatry. 2012;12(1):142.CrossRefPubMedPubMedCentral
13.
go back to reference Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, Katon WJ, Sullivan SD. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Sys Pharm. 2004;61(4):364–72. Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, Katon WJ, Sullivan SD. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Sys Pharm. 2004;61(4):364–72.
14.
go back to reference Mey A, Fowler JL, Knox K, Shum DH, Fejzic J, Hattingh L, McConnell D, Wheeler A. Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J. 2014;50(1):59–67. Mey A, Fowler JL, Knox K, Shum DH, Fejzic J, Hattingh L, McConnell D, Wheeler A. Review of community pharmacy staff educational needs for supporting mental health consumers and carers. Community Ment Health J. 2014;50(1):59–67.
15.
go back to reference Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009;29(8):975–87.CrossRefPubMed Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009;29(8):975–87.CrossRefPubMed
16.
go back to reference Brunero S, Lamont S, Fairbrother G. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Arch Psychiatr Nurs. 2009;23(3):261–8.CrossRefPubMed Brunero S, Lamont S, Fairbrother G. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Arch Psychiatr Nurs. 2009;23(3):261–8.CrossRefPubMed
17.
go back to reference Mant J. Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care. 2001;13(6):475–80.CrossRefPubMed Mant J. Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care. 2001;13(6):475–80.CrossRefPubMed
18.
go back to reference Donabedian A. The role of outcomes in quality assessment and assurance. QRB Qual Rev Bull. 1992;18(11):356.CrossRefPubMed Donabedian A. The role of outcomes in quality assessment and assurance. QRB Qual Rev Bull. 1992;18(11):356.CrossRefPubMed
19.
go back to reference Kröger E, Tourigny A, Morin D, Côté L, Kergoat M-J, Lebel P, Robichaud L, Imbeault S, Proulx S, Benounissa Z. Selecting process quality indicators for the integrated care of vulnerable older adults affected by cognitive impairment or dementia. BMC Health Serv Res. 2007;7(1):195. Kröger E, Tourigny A, Morin D, Côté L, Kergoat M-J, Lebel P, Robichaud L, Imbeault S, Proulx S, Benounissa Z. Selecting process quality indicators for the integrated care of vulnerable older adults affected by cognitive impairment or dementia. BMC Health Serv Res. 2007;7(1):195.
20.
go back to reference Shield T, Campbell S, Rogers A, Worrall A, Chew-Graham C, Gask L. Quality indicators for primary care mental health services. QSHC. 2003;12(2):100–6. Shield T, Campbell S, Rogers A, Worrall A, Chew-Graham C, Gask L. Quality indicators for primary care mental health services. QSHC. 2003;12(2):100–6.
22.
go back to reference Loeb JM. The current state of performance measurement in health care. Int J Qual Health Care. 2004;16 Suppl 1:5–9.CrossRef Loeb JM. The current state of performance measurement in health care. Int J Qual Health Care. 2004;16 Suppl 1:5–9.CrossRef
23.
go back to reference Rubin HR, Pronovost P, Diette GB. The advantages and disadvantages of process‐based measures of health care quality. Int J Qual Health Care. 2001;13(6):469–74.CrossRefPubMed Rubin HR, Pronovost P, Diette GB. The advantages and disadvantages of process‐based measures of health care quality. Int J Qual Health Care. 2001;13(6):469–74.CrossRefPubMed
24.
go back to reference Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27(5):367–83.CrossRefPubMed Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27(5):367–83.CrossRefPubMed
Metadata
Title
Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service
Authors
Husna Maulavizada
Lynne Emmerton
Hendrika Laetitia Hattingh
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1406-6

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue